Episode 55: Jessica Gibson, MBA, CEO and Co-Founder of Ariel Precision Medicine

TheSugarScience Podcast- curating the scientific conversation in type 1 diabetes
04/02/2021 17 min Episodio 55
Episode 55: Jessica Gibson, MBA, CEO and Co-Founder of Ariel Precision Medicine

Listen "Episode 55: Jessica Gibson, MBA, CEO and Co-Founder of Ariel Precision Medicine"

Descargar episodio Ver en sitio original

Episode Synopsis

In this episode, Jessica Gibson joins us to discuss the latest work at Ariel Precision Medicine. Ariel is a health technology company seamlessly integrating complex genetics into clinical decision-making, empowering doctors and patients to prevent, mitigate or even reverse disease progression. Ariel's initial focus is pancreatic diseases including pancreatitis, diabetes and pancreatic cancer.
Learn more about Ariel Precision Medicine here

More episodes of the podcast TheSugarScience Podcast- curating the scientific conversation in type 1 diabetes

Heard on the Street: Christopher Emfinger, PhD, University of Wisconsin-Madison 16/07/2024
Heard on the Street: Jeong Hun Jo, PhD, Washington University in St. Louis 15/07/2024
Heard on the Street: Christopher Acree, PhD Candidate, Vanderbilt University Medical Center 10/07/2024
Heard on the Street: Noyonika Mukherjee, PhD, Indiana Biosciences Research Institute 10/07/2024
Heard on the Street: Debjyoti Kundu, PhD, Indiana Biosciences Research Institute 10/07/2024
Heard on the Street: Michael Kalwat, PhD, Indiana Biosciences Research Institute's Diabetes Center 10/07/2024
Heard on the Street: Bart Roep, MD, Leiden University Medical Center 26/02/2024
Heard on the Street: Noel Morgan, PhD, University of Exeter 22/02/2024
Heard on the Street: Richard Oram, PhD, University of Exeter 22/02/2024
Heard on the Street: Tim Tree, PhD, Kings College London 22/02/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA